Data-Gouv-ML/pcri-informations-sur-les-projets-laureats huggingface dataset:
Early Marriage between Dynamism of Social Network and Legal Autonomy: The case of transnational Romanian Roma (NetRom)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Individual Fellowships (IF)-Standard European Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Social Sciences and Humanities
Countries involved: Italy
Call: Individual Fellowships (H2020-MSCA-IF-2017, 2017)
Start date: 2018-09-01
End date: 2020-08-31
Duration (months): 24.0
Total project cost (EUR): 180277.2
EU funding (EUR): 180277.2
Participants: 1
Project status: CLOSED

The issue of early marriage in Roma communities has been politicized through a negative view of reified cultural practices. I propose a new approach, situated at the crossroads of social anthropology, network analysis and law, in an attempt to include the issue of early marriage in the analysis of a human group, in terms of kinship and surrounding networks as well as the production of an autonomous legal structure. The study will privilege multi-situated participant observation of a kinship network in the originally eastern Romanian community that terms itself “Bessarabian Roma”. Today they have been settled in Milan and Paris for some fifteen years. Their practice of early marriage will be analysed with a focus on the importance of “women’s agency”. This choice also aims at the empowerment of educated Roma women sitting on a Romni Advisory Board set up for the purposes of the project. In proceeding in this way I hope to shed light on early marriage as a political issue by coming to understand the morphology of the kinship networks and the emic representations of marriage, whether judicial, symbolic or economic.

Keywords: roma,social network,kinship,early marriage,legal pluralism,woman agency,empowerment
Seedwiz Plant Variety OPTimizer Boosting Crop Growth for Global Food Security (SeedOPT)

Framework: Horizon 2020 — Industrial Leadership
Programme: Innovation in SMEs
Action type: SME instrument
Countries involved: Israel
Call: SME instrument (H2020-SMEInst-2018-2020-1, 2018)
Start date: 2018-08-01
End date: 2019-01-31
Duration (months): 6.0
Total project cost (EUR): 71429.0
EU funding (EUR): 50000.0
Participants: 1
Project status: CLOSED

The global population is growing fast. 60% more food will be needed by 2050, hence farming should be efficient and precise, considering a large number of parameters. Farmers must decide what crops to grow and which variety of seeds to select for optimal results, i.e. high yield & quality, low expenses and minimum use of harmful chemicals. For each crop there are many varieties available, and new ones are introduced annually. Today, there is no place where a farmer can receive comprehensive comparable info on seed varieties, taking into consideration all the parameters. Seedwiz’s SeedOPT platform empowers farmers with the knowledge to select optimal plant variety seeds. It is based on seed data that is continuously uploaded and updated by seed providers and includes a vast number of properties reflecting the genetic potential of the variety, combined with GIS & environmental data, farmer means of production and market needs. The parameters are analyzed by our AI algorithms, and provides farmers, for the first time, a comprehensive comparative matrix recommending the optimal varieties to use. The accumulated data in SeedOPT is highly valuable for the entire ag-industry. It included market trends, plant disease spread, crop yield forecasts and more. Compared to current solutions, which are limited, non-standardized and manual, SeedOPT is a unique, standardized, automated, and comprehensive platform freely accessible to any farmer. It is based on a clear win-win model between all key stakeholders in the market. Seedwiz seeks funding to conduct a feasibility study to prove technical and commercial viability in Europe, after successful beta pilots in CA, USA. During the project, it will conduct market and economic studies and engage stakeholders across Europe to demo SeedOPT, establish partnerships, and assess whether the chosen commercialization approach will lead to the projected growth, and what steps must be taken to commercially launch the system in Europe by 2020.

Keywords: seeds,plant varieties,food security,marketplace,ecommerce,data aggregation,farming,crop growing,precise agriculture,crop management,vegetable crops,comparative platform,crowd source,yield
Accelerating and upscaling transformational adaptation in Europe: demonstration of water-related innovation packages (TransformAr)

Framework: Horizon 2020 — Societal Challenges
Programme: Climate action, environment,  resource efficiency and raw materials
Action type: Innovation actions
Countries involved: Spain,Italy,Spain,Germany,Italy,Malta,Belgium,Norway,Finland,Belgium,Norway,Greece,Greece,Greece,Belgium,France,France,France,Czechia,United Kingdom
Call: Climate-resilient Innovation Packages for EU regions (H2020-LC-GD-2020-2, 2020)
Start date: 2021-10-01
End date: 2025-09-30
Duration (months): 48.0
Total project cost (EUR): 12730322.5
EU funding (EUR): 11872256.879999999
Participants: 24
Project status: SIGNED

Climate change impacts are here and now. The impacts on people, prosperity and planet are already pervasive but unevenly distributed, as stated in the new EU Blueprint strategy (European Commission-EC, 2019). To reduce climate-related risks, the EC and the IPCC agree that transformational adaptation is essential. The TranformAr project aims to develop and demonstrate products and services to launch and accelerate large-scale and disruptive adaptive process for transformational adaptation in vulnerable regions and communities across Europe. The 6 TransformAr lighthouse demonstrators face a common challenge: water-related risks and impacts of climate change. Based on existing successful initiatives, the project will develop, test and demonstrate solutions and pathways, integrated in Innovation Packages, in 6 territories. Transformational pathways, including an integrated risk assessment approach are co-developed by means of 9 Transformational Adaptive Blocks. A set of 22 tested actionable adaptive solutions are tested and demonstrated, ranging from nature-based solutions, innovative technologies, financing, insurance and governance models, awareness and behavioral change solutions. The project team, led by the University of Antwerp, gathers 22 partners from 11 countries and a well-balanced mix of sectoral and adaptation experts (5 RTOs and 1 SME), paired with 6 territories (4 local authorities and 2 charities), 8 additional solutions providers and 1 EU water-related NPO specialized that will support to structure a European Community of practice. Massive resilience increase and acceleration of transformation adaptation will be fostered by clustering various investors, testing bankable solutions, and defining viable (non-)commercial exploitation strategy for the TransformAr solutions, products and services.

Keywords: transformational adaptation,adaptive pathways,innovation packages,actionable adaptive solutions,water,investments,scale up
Tweaking dreams: non-invasive modulation of the level and content of mental activity during sleep (TweakDreams)

Framework: Horizon 2020 — Excellent Science
Programme: European Research Council (ERC)
Theme: European research council
Destination: Starting grants
Action type: ERC actions
Panel: The Human Mind and Its Complexity
Panel description: Cognitive science, psychology, linguistics, theoretical philosophy
Countries involved: Italy
Call: ERC STARTING GRANTS (ERC-2020-STG, 2020)
Start date: 2021-05-01
End date: 2026-10-31
Duration (months): 66.0
Total project cost (EUR): 1488270.0
EU funding (EUR): 1488270.0
Participants: 1
Project status: SIGNED

Sleep and wakefulness have traditionally been regarded as two mutually exclusive states characterized by differences in consciousness and responsiveness to the environment. However, the last two decades of research have demonstrated that sleep is actually a locally regulated phenomenon and that cortical islands of sleep- and wake-like activity can often coexist across distinct brain areas. Intriguingly, this mosaic of activity is also directly related to the presence and content of mental activity during sleep. In line with this, many sleep disorders, including insomnia and arousal disorders, are associated with significant local alterations in the balance between wake- and sleep-like activity. In spite of these considerations, the classical view of sleep as a uniform global state is still dominant in both basic and clinical research. Moreover, it remains unclear whether the occurrence of local wake-like activity is related to specific physiological functions of sleep. The objective of this project is to progress towards a deep understanding of the mechanisms that regulate sleep at a local level through the exploitation of known properties of the thalamocortical system. At the core of the proposal is the idea that particular sensory-stimulation protocols may allow to directly modulate sleep intensity in a local, region-specific manner. Such approaches could be used to non-invasively perturbate regional sleep-related brain activity, thus allowing to investigate the causal consequences on sleep mentation, subjective sleep quality and sleep-related functions, including learning and memory. Of note, the same approaches could also find application in counteracting alterations of local sleep regulation in pathological conditions. Knowledge gathered within the project could yield potential breakthroughs in numerous key applications of tremendous clinical, social and economic interest including treatment of sleep disorders and prevention of sleepiness-related accidents.

Keywords: sleep,dreams,electroencephalography
COVID-19 infections - Remote Early Detection (COVID-RED)

Framework: Horizon 2020 — Societal Challenges
Programme: Health, demographic change and wellbeing
Theme: Public-private partnerships
Destination: Innovative Medicines Initiative 2
Action type: Research and Innovation actions
Partnership: IMI2 (Art-187)
Countries involved: Switzerland,Switzerland,Netherlands,Netherlands,Netherlands,United Kingdom,Denmark
Call: Development of therapeutics and diagnostics combatting coronavirus infections (H2020-JTI-IMI2-2020-21-single-stage, 2020)
Start date: 2020-07-01
End date: 2022-12-31
Duration (months): 30.0
Total project cost (EUR): 10329253.75
EU funding (EUR): 9592028.75
Participants: 11
Project status: SIGNED

In this project, we will evaluate the use and performance of a CE-marked device (wearable), which uses sensors to measure breathing rate, pulse rate, skin temperature, and heart rate variability for the purpose of early detection and monitoring of COVID-19 in general and high-risk populations. At the same time, a mobile application will be used to track participant-reported symptoms. A prospective, observational study will follow 13,000 individuals from the general population and 7,000 high-risk individuals wearing the device and responding to participant self-report parameters via a purpose-designed app. Based on this data, an algorithm will indicate which individuals likely require general practitioner (GP) care (for COVID-19 diagnostic testing, further vital signs assessment, and/or treatment) and/or hospital care. To evaluate algorithm performance, the cohort will be tested for COVID-19 antibodies at the end of follow-up. COVID-19 seropositivity in the intervention cohort will be compared seropositivity in a control population of 20,000 individuals drawn from the same populations using the application only. Thus, this project will deliver a large body of information on COVID-19 PCR testing and antibodies that can be used to develop additional diagnostics and therapeutics in addition to validating remote vital signs and self-reported symptoms monitoring systems.

Keywords: remote detection,early warning,covid 19,mobile health,wearables
Peer learning in business innovation tools for SMEs (Peer-BIT)

Framework: Horizon 2020 — Industrial Leadership
Programme: Innovation in SMEs
Action type: Coordination and support actions
Countries involved: Austria,Lithuania,Czechia
Call: peer learning of innovation agencies (H2020-INNOSUP-2014-5, 2014)
Start date: 2015-10-01
End date: 2016-09-30
Duration (months): 12.0
Total project cost (EUR): 50000.0
EU funding (EUR): 50000.0
Participants: 3
Project status: CLOSED

The Peer-BIT project will increase the quality of innovation support services provided for SMEs in area of innovation management. In line with the trend of individualization of SME support services, the project will explore tools that are easy to use, yet flexible and ready to be customized to the specific needs of an SME. The Peer-BIT builds on smE-MPOWER methodology that represents state-of-the art approach and consists of number of tools that are used in the process of coaching SMEs towards business innovation. Although smE-MPOWER was validated and enhanced internationally in EU FP7 funded project, only few innovation support programmes using the methodology are in place throughout the EU. The main objective of the project is therefore to increase efficiency of smE-MPOWER implementation through peer learning. Two of the partners (JIC and LIC) have to various degrees implemented smE-MPOWER into their programmes, whereas the third partner (TMG) has no previous smE-MPOWER experience, but has a long track record of providing innovation support services. Peer-BIT will develop activities aimed at accelerating learning process among the project partners, their coaches and experts in smE-MPOWER. In particular, two peer review workshops will be organized with real-case coaching elements that will provide partner agencies with an authentic experience of service delivery on real case examples of SMEs. As a result Peer-BIT will increase quality of existing services based on smE-MPOWER and will facilitate uptake of the methodology by TMG and other agencies. The know-how in implementing smE-MPOWER tools that will be built up in course of the project will be then codified in the Design Option Paper, a step by step guidance on designing smE-MPOWER-based innovation support programme. Peer-BIT will contribute to the effort of improving, or setting up of new SME innovation management support services in EU.

Keywords: innovation management in smes,sme mpower methodology
TheraPD: Smart and safer automated peritoneal dialysis by means of sterile connectivity, bio-sensors control systems and more biocompatible solutions for preventing rapid degradation of peritoneal mem (TheraPD)

Framework: Horizon 2020 — Societal Challenges
Programme: Health, demographic change and wellbeing
Theme: Treating and managing disease
Action type: SME instrument
Countries involved: Italy
Call: Supporting innovative SMEs in the healthcare biotechnology sector (H2020-SMEINST-2-2016-2017, 2016)
Start date: 2016-10-01
End date: 2019-08-31
Duration (months): 35.0
Total project cost (EUR): 2838126.25
EU funding (EUR): 2838126.25
Participants: 1
Project status: TERMINATED

2.7 million People worldwide (250,000 Europeans) have kidney transplants or undergo a dialysis treatment because of irreversible end-stage renal disease (ESRD). This number has more than doubled over the past 15 years and involves 3-5% of NHS budgets. Current therapy consist in either a kidney transplant, haemodialysis connected to a machine at the hospital for at least 3h, 3 times a week, or the better-outcome cost-effective home-based peritoneal dialysis (PD). Although widely demonstrated to have greater results and to be cost-effective, PD is only used in 11% of the cases because of its drawbacks: peritonitis (35% dropout), poorly biocompatible solutions available, and overfilling of the peritoneal cavity causing rapid degradation on the mesothelium membrane. Our innovative TheraPD solution provide the most safe and efficient automated peritoneal dialysis therapy to date. It entails a comprehensive system composed by a sterile connector (renders peritonitis risk almost zero), a biosensing control system (avoids overfilling), and a new biocompatible dialysate which prevents degradation of peritoneal membrane cells. Another innovation is that our cycler will be equipped with special biosensors to measure the concentration of glucose and pH, this allows to customize the dialysis prescription according to the ultrafiltration capacity of the patient, increases safety level of the treatment and it allows to monitor the uptake of glucose by the patient. By solving these unmet clinical needs, we will increase PD usage by expanding it to people who were not previously eligible, reduce treatment frequency or duration, customize the dialysis treatment according to the response of the patient’s body, increase patients’ comfort and significantly reduce healthcare spending. With EC’s support we will achieve all these societal and individual benefits while earning €4.7M profit, penetrating 1.15% of the world market, and generating a solid ROI of 1.65 after 5 years from launch.

Keywords: kidney transplant,haemodialysis,home based biocompatible solutions,safe and efficient automated peritoneal dialysis therapy
Dynamics of Complex Continua (DOCC)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Co-funding of regional, national and international programmes (COFUND)-Doctoral programmes
Action type: Marie Skłodowska-Curie actions
Countries involved: Austria
Call: Co-funding of regional, national and international programmes (H2020-MSCA-COFUND-2018, 2018)
Start date: 2019-06-01
End date: 2024-05-31
Duration (months): 60.0
Total project cost (EUR): 2440800.0
EU funding (EUR): 1220400.0
Participants: 1
Project status: SIGNED

DOCC is an interdisciplinary doctoral programme at the University of Innsbruck for 15 international early-stage researchers on modelling and simulation in physics, chemistry, atmospheric sciences, material and engineering sciences, mathematics and computer science. DOCC provides structured advanced training in both research-relevant and professional skills, by building expertise in the intersectorally seminal fields of computational material, fluid and gas dynamics, which procure multiple topical technological, societal and medical applications relevant to climate, energy, safety, or nano and life sciences. All of these areas require a capability for predictive modelling and in-depth understanding of structural and dynamical properties of matter and materials, which often show a high level of dynamic complexity. In our research focus on "Dynamics Of Complex Continua" (DOCC) we develop and apply novel methods for theoretical and numerical analysis in modelling and simulation of dynamical processes, such as stability, nonlinearity, transport and structure formation. In particular we consider meso- and macroscopic many-body and continuum systems of solids, soft matter, liquids, gases and plasmas, that are characterised by complex couplings between its constituents, its environment, or multi-scale dependence. DOCC prepares Europe's next top modellers to link simulations and the real world within a multi-disciplinary environment, by providing beyond essential technical expertise also the training in key abilities to communicate and transfer methods and results. Targeted education in communication and knowledge-transfer skills is therefore implemented as a central supplementary pillar within the DOCC programme. The fellows will be provided with possibilities and encouragement to assume secondments to renowned international and regional academic and intersectoral partner organisations.

Keywords: interdisciplinary physics based modelling,numerical simulation,scientific computing,physics,engineering,material science,chemistry,geosciences,life sciences,mathematics
Cardiovascular Diseases Diagnoses by means of Smart Remote Monitoring System based on known Heart Activity Biomarkers (HELMO)

Framework: Horizon 2020 — Societal Challenges
Programme: Health, demographic change and wellbeing
Theme: Treating and managing disease
Action type: SME instrument
Countries involved: Italy
Call: Clinical research for the validation of biomarkers and/or diagnostic medical devices (H2020-SMEINST-1-2014, 2014)
Start date: 2015-05-01
End date: 2015-08-31
Duration (months): 4.0
Total project cost (EUR): 71429.0
EU funding (EUR): 50000.0
Participants: 1
Project status: CLOSED

Cardiovascular Diseases are the leading global cause of death, accounting for 17.3 million deaths per year, a number that is expected to grow to >23.6 million by 2030. In Europe, it accounts for over 4 million deaths each year which means nearly half 47% of all deaths. Overall CVD is estimated to cost the EU economy almost €196 billion a year. It is clear that there is an economic demand to implement cost effective measures to early diagnoses of CVD and detection of highs risks to suffer a fatal event. The WHO has prioritized these interventions as: early identification of people at high risk in primary care and monitoring of survivors of a heart attack or stroke which are at high risk of recurrences or dying from them. Indeed, spurred by the hefty bill and lack of resources, Hospitals are continuously looking for new solutions to allow them to discharged chronical inpatients who can be remotely monitoring improving its quality of life and providing tailored treatment. The project HELMO aims at developing and clinically validating a no-invasive remote monitoring medical device for the early diagnoses of cardio vascular diseases (CVD) and to provide assistance before fatal consequences, even death. The product will be launched to the market as an innovative system able to monitor remotely 10 vital parameters which are well known biomarkers of CVD diseases: ECG – 12 leads ECG -, heart and breath rates, blood pressure, movement, oxygen saturation, body temperature, sweat, calories, location. This device, designed by all population including special needs group, will provide alerts both patients and clinicians at critical moments which can lead to loss of consciousness and death. As a result, the number of hospitalization caused by CVD and eventually the deaths will experiment a significant reduction. HELMO is a non-invasive medical device based on the monitoring of CVD biomarkers which commercialization will mean €14.4 M revenues for XEOS by 2022.

Keywords: patient remote monitoring,diagnoses medical device,ehealth,mhealth,cardiovascular diseases,vital parameters,heart biomarkers